STEMTECH CORPORATION Stock Price, News & Analysis

Stemtech Corporation (OTCQB: STEK), a leader in nutraceuticals, announced the launch of new stem cell skincare products. CEO John W. Meyer expressed excitement about expanding their offerings at the upcoming Cancun Incentive Meeting in December. The global skincare market is projected to grow significantly, and Stemtech aims to leverage its scientific advancements in stem cell technology to capture market share. The company believes this product line will provide growth and revenue opportunities for its Independent Business Partners and enhance the overall customer experience.

Stemtech Corporation (OTCQB: STEK) announced the Go-Live date for its Stemtech Advance Office on September 19, 2022. Developed with VERB Technology Company, Inc. (NASDAQ: VERB), the platform aims to enhance communication and business capabilities for Independent Business Partners (IBPs). President John W. Meyer highlighted the software's potential to improve recruiting and retention efforts, leveraging interactive video-based sales applications. Stemtech, known for its patent-protected nutraceutical products supporting adult stem cell release, is positioned to increase its market momentum through this strategic partnership.

Stemtech Corporation (OTCQB: STEK) announces the appointment of Professor Dr. Bankole Johnson to its Life Sciences Advisory Board. Dr. Johnson, a highly regarded figure in the medical field, is expected to provide valuable insights as Stemtech focuses on enhancing health through science. His extensive background includes roles at the University of Virginia and the University of Maryland, along with recognition for his work in addiction treatment. This addition aligns with Stemtech's strategy to advance its proprietary health products and strengthen its leadership.

Stemtech Corporation (OTCQB: STEK) has issued a Letter of Intent to acquire Life Factor Research, enhancing its R&D capabilities in stem cell nutrition and related products. This acquisition is expected to position Stemtech at the forefront of advanced stem cell technology, allowing quicker market penetration of innovative health products. The collaboration aims to cater to an expanding market with a focus on anti-aging and longevity. The CEO of Life Factor Research highlights the potential for redefining market standards through this partnership.

Stemtech Corporation (OTCQB: STEK), a leader in nutraceuticals, has announced its sponsorship of the ADVENT EXPO. This event aims to connect millions of viewers globally in a virtual metaverse setting, promoting Stemtech's anti-aging and plant-based stem cell nutrition products. President John W. Meyer emphasized the exposure opportunities provided by the Expo, which combines health and financial aspects for potential consumers. Stemtech's products, which are patented and all-natural, are produced under stringent manufacturing practices.

Stemtech Corporation (OTCQB: STEK) announced the trademark registration of OraStem®, its all-natural toothpaste, in Mexico. This registration signifies the company's commitment to protecting its intellectual property, benefiting its Independent Business Partners and customers. OraStem boasts 14 natural ingredients, providing anti-oxidative, anti-microbial protection, and supports oral health at a cellular level. The product's efficacy is backed by numerous peer-reviewed studies. Additionally, a new travel size of OraStem will launch soon, enhancing product accessibility.

Stemtech Corporation (OTCQB: STEK), a Florida-based nutraceutical company, announced the adoption of VERB's interactive video-based sales tools to enhance customer engagement and increase sales conversion rates. The platform includes verbCRM and verbLIVE, facilitating direct sales efforts by Independent Business Partners (IBPs). Stemtech, known for its patent-protected stem cell nutrition products, aims to empower its IBPs with advanced digital tools, leveraging social media for customer acquisition. This collaboration is expected to boost marketing effectiveness and sales performance.

Stemtech Corporation (OTCQB:STEK) announced the appointment of Izzy Matos as Founding Independent Business Partner. Matos, a key figure since the company's inception in 2005, previously developed the compensation plan and built a personal network of over 70,000 individuals. A graduate of the Network Marketing Hall of Fame, he aims to leverage this new role to enhance Stemtech's growth. The company, known for its patented stem cell nutrition products, has a strong history of recognition, having appeared on the Inc. 5000 Fastest-Growing Companies list multiple times.